Clinical trial
Diazoxide in the Treatment of Type 1 Glycogenosis
NCT07739394 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diazoxide in the Treatment of Type 1 Glycogenosis
- Lead sponsor
- Central Hospital, Nancy, France
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- August 30, 2026
- Completion date
- October 15, 2027
- Enrollment
- 15 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.